pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer
Abstract Background Multidrug resistance (MDR) generally leads to breast cancer treatment failure. The most common mechanism of MDR is the overexpression of ATP-binding cassette (ABC) efflux transporters such as P-glycoprotein (P-gp) that reduce the intracellular accumulation of various chemotherape...
Main Authors: | Sipei Zhang, Nan Guo, Guoyun Wan, Tao Zhang, Chunyu Li, Yongfei Wang, Yinsong Wang, Yuanyuan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12951-019-0540-9 |
Similar Items
-
Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
by: Ping Zhou, et al.
Published: (2017-09-01) -
INFLUENCE OF A LOW-DOSE COX-2 INHIBITOR DRUG ON EXERCISE-INDUCED INFLAMMATION, MUSCLE DAMAGE AND LIPID PEROXIDATION
by: Babak Nakhostin-Roohi, et al.
Published: (2013-01-01) -
Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy
by: Carlos Rosas, et al.
Published: (2014-01-01) -
Synthesis and evaluation of ortho-[18F]fluorocelecoxib for COX-2 cholangiocarcinoma imaging
by: Chang CW, et al.
Published: (2018-05-01) -
COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs
by: Evrim eGurpinar, et al.
Published: (2013-07-01)